Rockwell Medical (RMTI) Short term Debt (2013 - 2026)

Rockwell Medical has reported Short term Debt for 11 years, with the latest figure at $707000.0 in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt fell 70.98% year-over-year to $707000.0; the trailing twelve-month figure through Mar 2026 stood at $707000.0 (down 70.98% YoY), and the FY2024 full-year result was $2.4 million, down 5.16% from the prior year.
• Short term Debt for Q1 2026 stood at $707000.0, down from $1.8 million in the prior quarter.
• The five-year high for Short term Debt was $6.6 million in Q1 2022, with the low at $707000.0 in Q1 2026.
• Historically, Short term Debt has averaged $3.1 million across 5 years, with a median of $2.5 million in 2023.
• Annual changes were most pronounced in 2022 — Short term Debt surged 3777.78% — and 2026, when it sank 70.98%.
• Rockwell Medical's Short term Debt stood at $5.1 million in 2022, then tumbled by 51.28% to $2.5 million in 2023, then slipped by 5.16% to $2.4 million in 2024, then dropped by 24.08% to $1.8 million in 2025, then slumped by 60.72% to $707000.0 in 2026.
• The last three Short term Debt figures came in at $707000.0 (Q1 2026), $1.8 million (Q3 2025), and $2.5 million (Q2 2025), per Business Quant data.